Discovery and structure-activity relationships (SAR) of a novel class of 2-substituted N-piperidinyl indole-based nociceptin opioid receptor ligands

被引:2
作者
Meyer, Michael E. [1 ]
Doshi, Arpit [1 ]
Polgar, Willma E. [1 ]
Zaveri, Nurulain T. [1 ]
机构
[1] Astraea Therapeut LLC, 320 Logue Ave,Suite 142, Mountain View, CA 94043 USA
关键词
Nociceptin opioid receptor; mu opioid receptor; N/OFQ; NOP; MOP; Nociceptin full agonist; Nociceptin partial agonist; Bifunctional agonist; Structure -based drug design; Structure activity relationship; G -protein coupled receptor; Orthosteric binding site; CONDITIONED PLACE PREFERENCE; ORPHANIN FQ RECEPTOR; TISSUE DISTRIBUTION; MOLECULAR-CLONING; NOP; MEMBER; AGONIST; BINDING; ORL1; ACQUISITION;
D O I
10.1016/j.bmc.2023.117421
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The development of SAR around substituted N-piperidinyl indole-based nociceptin opioid receptor (NOP) ligands led to the discovery of a novel series of 2-substituted N-piperidinyl indoles that provide both selective NOP full agonists and bifunctional NOP full agonists-& mu; opioid (MOP) receptor partial agonists. 2-substituted N-piperidinyl indoles have improved potency at the NOP receptor and are NOP full agonists, compared to our previously reported 3-substituted N-piperidinyl indoles that are selective NOP partial agonists. SAR in this series of 2 -substituted N-piperidinyl indoles shows that 2-substitution versus 3-substitution on the indole moiety affects their intrinsic activity and opioid receptor selectivity. Molecular docking of these 2-substituted N-piperidinyl indoles in an active-state NOP homology model and MOP receptor structures provides a rationale for the dif-ferences observed in the binding, functional profiles and selectivity of 2-substituted versus 3-substituted N-piperidinyl indoles.
引用
收藏
页数:11
相关论文
共 37 条
[21]  
Mercatelli D, 2019, HANDB EXP PHARMACOL, V254, P213, DOI 10.1007/164_2018_199
[22]   ISOLATION AND STRUCTURE OF THE ENDOGENOUS AGONIST OF OPIOID RECEPTOR-LIKE ORL(1) RECEPTOR [J].
MEUNIER, JC ;
MOLLEREAU, C ;
TOLL, L ;
SUAUDEAU, C ;
MOISAND, C ;
ALVINERIE, P ;
BUTOUR, JL ;
GUILLEMOT, JC ;
FERRARA, P ;
MONSARRAT, B ;
MAZARGUIL, H ;
VASSART, G ;
PARMENTIER, M ;
COSTENTIN, J .
NATURE, 1995, 377 (6549) :532-535
[23]   Structure-Based SAR in the Design of Selective or Bifunctional Nociceptin (NOP) Receptor Agonists [J].
Meyer, Michael E. ;
Doshi, Arpit ;
Yasuda, Dennis ;
Zaveri, Nurulain T. .
AAPS JOURNAL, 2021, 23 (03)
[24]   ORL1, A NOVEL MEMBER OF THE OPIOID RECEPTOR FAMILY - CLONING, FUNCTIONAL EXPRESSION AND LOCALIZATION [J].
MOLLEREAU, C ;
PARMENTIER, M ;
MAILLEUX, P ;
BUTOUR, JL ;
MOISAND, C ;
CHALON, P ;
CAPUT, D ;
VASSART, G ;
MEUNIER, JC .
FEBS LETTERS, 1994, 341 (01) :33-38
[25]  
Moulédous L, 2019, HANDB EXP PHARMACOL, V254, P259, DOI 10.1007/164_2018_185
[26]   Identification of the G-protein-coupled ORL1 receptor in the mouse spinal cord by [35S]-GTPγS binding and immunohistochemistry [J].
Narita, M ;
Mizoguchi, H ;
Oji, DE ;
Narita, M ;
Dun, NJ ;
Hwang, BH ;
Nagase, H ;
Tseng, LF .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 128 (06) :1300-1306
[27]   ORPHANIN-FQ - A NEUROPEPTIDE THAT ACTIVATES AN OPIOID-LIKE G-PROTEIN-COUPLED RECEPTOR [J].
REINSCHEID, RK ;
NOTHACKER, HP ;
BOURSON, A ;
ARDATI, A ;
HENNINGSEN, RA ;
BUNZOW, JR ;
GRANDY, DK ;
LANGEN, H ;
MONSMA, FJ ;
CIVELLI, O .
SCIENCE, 1995, 270 (5237) :792-794
[28]   Nociceptin/orphanin FQ microinjected into hippocampus impairs spatial learning in rats [J].
Sandin, J ;
Georgieva, J ;
Schott, PA ;
Ogren, SO ;
Terenius, L .
EUROPEAN JOURNAL OF NEUROSCIENCE, 1997, 9 (01) :194-197
[29]   Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems [J].
Toll, Lawrence ;
Bruchas, Michael R. ;
Calo', Girolamo ;
Cox, Brian M. ;
Zaveri, Nurulain T. .
PHARMACOLOGICAL REVIEWS, 2016, 68 (02) :419-457
[30]   Comparison of the Antinociceptive and Antirewarding Profiles of Novel Bifunctional Nociceptin Receptor/μ-Opioid Receptor Ligands: Implications for Therapeutic Applications [J].
Toll, Lawrence ;
Khroyan, Taline V. ;
Polgar, Willma E. ;
Jiang, Faming ;
Olsen, Cris ;
Zaveri, Nurulain T. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 331 (03) :954-964